serw-MX
[
xml
]
Antihyperglycemics
CID10 - Classificação Internacional de Doenças
DeCS Português
DeCS Inglês
DeCS Espanhol
DeCS Espanha
DeCS Português com escopo
DeCS Inglês com escopo
DeCS Espanhol com escopo
DeCS Espanha com escopo
LILACS - LILACS Regional
Categorias DeCS
B01
Eukaryota
.
B01.050
Animals
.
B01.050.150
Chordata
.
B01.050.150.900
Vertebrates
.
B01.050.150.900.649
Mammals
.
B01.050.150.900.649.313
Eutheria
.
B01.050.150.900.649.313.992
Rodentia
.
B01.050.150.900.649.313.992.635
Muridae
.
B01.050.150.900.649.313.992.635.505
Murinae
.
B01.050.150.900.649.313.992.635.505.500
Mice 6757
.
B01.050.150.900.649.313.992.635.505.500.550
Mice, Mutant Strains
.
B01.050.150.900.649.313.992.635.505.500.550.530
Mice, Obese
.
C18
Nutritional and Metabolic Diseases
.
C18.452
Metabolic Diseases
.
C18.452.394
Glucose Metabolism Disorders
.
C18.452.394.952
Hyperglycemia
.
D27
Chemical Actions and Uses
.
D27.505
Pharmacologic Actions
.
D27.505.519
Molecular Mechanisms of Pharmacological Action
.
D27.505.519.186
Antimetabolites
.
D27.505.519.186.071
Hypolipidemic Agents
.
D27.505.696
Physiological Effects of Drugs
.
D27.505.696.422
Hypoglycemic Agents
.
D27.505.696.560
Natriuretic Agents
.
D27.505.696.560.374
Antihyperkalemic Agents
.
D27.505.954
Therapeutic Uses
.
D27.505.954.329
Antirheumatic Agents
.
D27.505.954.329.337
Gout Suppressants
.
D27.505.954.557
Lipid Regulating Agents
.
D27.505.954.557.500
Hypolipidemic Agents
.
Termos
Sinônimos e Históricos
Documentos
LILACS e MDL
Hypoglycemic Agents
.
Antidiabetic Agents
.
Antidiabetic Drugs
.
Antihyperglycemic Agents
.
Antihyperglycemics
.
Hypoglycemic Drugs
.
Hypoglycemic Effect
.
Hypoglycemic Effects
.
Hypoglycemics
.
Agents, Antidiabetic
.
Agents, Antihyperglycemic
.
Agents, Hypoglycemic
.
Drugs, Antidiabetic
.
Drugs, Hypoglycemic
.
Effect, Hypoglycemic
.
Effects, Hypoglycemic
.
Antidiabetics
.
1.00
Gout Suppressants
.
Antihyperuricemics
.
Agents, Antigout
.
Suppressants, Gout
.
Antigout Agents
.
0.70
Hypolipidemic Agents
.
Antihyperlipemics
.
Antihyperlipidemics
.
Antilipemic Drugs
.
Antilipemics
.
Hypolipidemic Drugs
.
Agents, Antilipemic
.
Agents, Hypolipidemic
.
Drugs, Antilipemic
.
Drugs, Hypolipidemic
.
Antilipemic Agents
.
ANTILIPIDERMIC AGENTS
.
0.64
Hyperglycemia
.
Hyperglycemia, Postprandial
.
Hyperglycemias
.
Hyperglycemias, Postprandial
.
Postprandial Hyperglycemias
.
Postprandial Hyperglycemia
.
0.63
Antihyperkalemic Agents
.
Antihyperkalemic Drugs
.
Antihyperkalemics
.
Agents, Antihyperkalemic
.
Drugs, Antihyperkalemic
.
0.63
Mice, Obese
.
Mouse, Hyperglycemic
.
Mouse, Obese
.
Hyperglycemic Mouse
.
Mice, Hyperglycemic
.
Obese Mouse
.
Obese Mice
.
Hyperglycemic Mice
.
0.59